159 related articles for article (PubMed ID: 30569290)
1. The Scorpion Venom Peptide Smp76 Inhibits Viral Infection by Regulating Type-I Interferon Response.
Ji Z; Li F; Xia Z; Guo X; Gao M; Sun F; Cheng Y; Wu Y; Li W; Ali SA; Cao Z
Virol Sin; 2018 Dec; 33(6):545-556. PubMed ID: 30569290
[TBL] [Abstract][Full Text] [Related]
2. Smp76, a Scorpine-Like Peptide Isolated from the Venom of the Scorpion
El-Bitar AMH; Sarhan M; Abdel-Rahman MA; Quintero-Hernandez V; Aoki-Utsubo C; Moustafa MA; Possani LD; Hotta H
Int J Pept Res Ther; 2020; 26(2):811-821. PubMed ID: 32435168
[TBL] [Abstract][Full Text] [Related]
3. A scorpion venom peptide Ev37 restricts viral late entry by alkalizing acidic organelles.
Li F; Lang Y; Ji Z; Xia Z; Han Y; Cheng Y; Liu G; Sun F; Zhao Y; Gao M; Chen Z; Wu Y; Li W; Cao Z
J Biol Chem; 2019 Jan; 294(1):182-194. PubMed ID: 30404919
[TBL] [Abstract][Full Text] [Related]
4. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.
Pryke KM; Abraham J; Sali TM; Gall BJ; Archer I; Liu A; Bambina S; Baird J; Gough M; Chakhtoura M; Haddad EK; Kirby IT; Nilsen A; Streblow DN; Hirsch AJ; Smith JL; DeFilippis VR
mBio; 2017 May; 8(3):. PubMed ID: 28465426
[TBL] [Abstract][Full Text] [Related]
5. Carnosine exhibits significant antiviral activity against Dengue and Zika virus.
Rothan HA; Abdulrahman AY; Khazali AS; Nor Rashid N; Chong TT; Yusof R
J Pept Sci; 2019 Aug; 25(8):e3196. PubMed ID: 31290226
[TBL] [Abstract][Full Text] [Related]
6. Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane.
Oeyen M; Meyen E; Noppen S; Claes S; Doijen J; Vermeire K; Süssmuth RD; Schols D
Virology; 2021 Oct; 562():74-86. PubMed ID: 34274562
[TBL] [Abstract][Full Text] [Related]
7. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.
Carlin AF; Plummer EM; Vizcarra EA; Sheets N; Joo Y; Tang W; Day J; Greenbaum J; Glass CK; Diamond MS; Shresta S
Cell Rep; 2017 Nov; 21(6):1600-1612. PubMed ID: 29117564
[TBL] [Abstract][Full Text] [Related]
8. Scorpion Venom Antimicrobial Peptides Induce Siderophore Biosynthesis and Oxidative Stress Responses in Escherichia coli.
Tawfik MM; Bertelsen M; Abdel-Rahman MA; Strong PN; Miller K
mSphere; 2021 May; 6(3):. PubMed ID: 33980680
[TBL] [Abstract][Full Text] [Related]
9. The Polyphenol-Rich Extract from
Clain E; Haddad JG; Koishi AC; Sinigaglia L; Rachidi W; Desprès P; Duarte Dos Santos CN; Guiraud P; Jouvenet N; El Kalamouni C
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991717
[TBL] [Abstract][Full Text] [Related]
10. Scorpion Venom Antimicrobial Peptide Derivative BmKn2-T5 Inhibits Enterovirus 71 in the Early Stages of the Viral Life Cycle
Xia Z; Wang H; Chen W; Wang A; Cao Z
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785952
[TBL] [Abstract][Full Text] [Related]
11. Virocidal activity of Egyptian scorpion venoms against hepatitis C virus.
El-Bitar AM; Sarhan MM; Aoki C; Takahara Y; Komoto M; Deng L; Moustafa MA; Hotta H
Virol J; 2015 Mar; 12():47. PubMed ID: 25889296
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification and virucidal activity of two recombinant isoforms of phospholipase A
Russo RR; Dos Santos Júnior NN; Cintra ACO; Figueiredo LTM; Sampaio SV; Aquino VH
Arch Virol; 2019 Apr; 164(4):1159-1171. PubMed ID: 30809709
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).
Pires de Mello CP; Drusano GL; Rodriquez JL; Kaushik A; Brown AN
Viruses; 2018 Jun; 10(6):. PubMed ID: 29890736
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus.
Pitts JD; Li PC; de Wispelaere M; Yang PL
Antiviral Res; 2017 Nov; 147():124-130. PubMed ID: 29051080
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses.
Webster B; Werneke SW; Zafirova B; This S; Coléon S; Décembre E; Paidassi H; Bouvier I; Joubert PE; Duffy D; Walzer T; Albert ML; Dreux M
Elife; 2018 Jun; 7():. PubMed ID: 29914621
[TBL] [Abstract][Full Text] [Related]
16. Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses.
Flipse J; Diosa-Toro MA; Hoornweg TE; van de Pol DP; Urcuqui-Inchima S; Smit JM
Sci Rep; 2016 Jul; 6():29201. PubMed ID: 27380892
[TBL] [Abstract][Full Text] [Related]
17. A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses.
Yu Y; Deng YQ; Zou P; Wang Q; Dai Y; Yu F; Du L; Zhang NN; Tian M; Hao JN; Meng Y; Li Y; Zhou X; Fuk-Woo Chan J; Yuen KY; Qin CF; Jiang S; Lu L
Nat Commun; 2017 Jul; 8():15672. PubMed ID: 28742068
[TBL] [Abstract][Full Text] [Related]
18. Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds.
Kaptein SJF; Vincetti P; Crespan E; Rivera JIA; Costantino G; Maga G; Neyts J; Radi M
ChemMedChem; 2018 Jul; 13(14):1371-1376. PubMed ID: 29740962
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus.
Snyder B; Goebel S; Koide F; Ptak R; Kalkeri R
J Med Virol; 2018 Jan; 90(1):8-12. PubMed ID: 28851097
[TBL] [Abstract][Full Text] [Related]
20. Immune Response to Dengue and Zika.
Ngono AE; Shresta S
Annu Rev Immunol; 2018 Apr; 36():279-308. PubMed ID: 29345964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
